Decheng Capital »

Arcus Biosciences Incorporated shares owned by Decheng Capital

Quarter-by-quarter ownership of Arcus Biosciences Incorporated (RCUS) shares owned by Decheng Capital from 13F filings

Historical chart of Decheng Capital investment in Arcus Biosciences Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Arcus Biosciences Incorporated held by Decheng Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcus Biosciences Incorporated by Decheng Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $13M 870k 15.29
2024-06-30 $13M 870k 15.23
2024-03-31 $16M 870k 18.88
2023-12-31 $17M 870k 19.10

More positions owned by Decheng Capital

Cg Oncology (CGON)
Nuvation Bio (NUVB)
Phathom Pharmaceuticals (PHAT)
Arcus Biosciences Incorporated (RCUS)
Krystal Biotech (KRYS)
Illumina (ILMN)
Zentalis Pharmaceuticals (ZNTL)
BeyondSpring SHS (BYSI)
Newamsterdam Pharma Co Nv (NAMS)
Merus N V (MRUS)
Helix Acquisition Corp
Crinetics Pharmaceuticals In (CRNX)
Legend Biotech Corp- Adr (LEGN)
Cytokinetics (CYTK)
Aura Biosciences (AURA)

View all positions for Decheng Capital

Top funds holding Arcus Biosciences Incorporated

Gilead Sciences
BlackRock
Vanguard Group
FMR
Woodline Partners
State Street Corporation
Point72 Asset Management
Dimensional Fund Advisors
Siren
Boxer Capital Management
Ameriprise Financial
Bnp Paribas Investment Partners
Parkman Healthcare Partners
Geode Capital Management
Millennium Management

View all funds holding Arcus Biosciences Incorporated